Xtant Medical Posts 20.5% Orthobiologics Growth in 2Q17

Xtant Medical posted 2Q17 revenue of US $21.4MM, -0.3% vs. 2Q16, with 1H17 revenue of $43.5MM, +2.5% vs. 1H16. Gains in orthobiologic product sales were balanced out almost evenly by decreases in fixation hardware revenue.

ORTHOWORLD estimates segment revenue and as-reported growth as follows.

Q17 ...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us